[Pathogenic mechanism of type 2 diabetes mellitus from impaired glucose tolerance/borderline type and its reversibility].
Yoshimoto
Katsuhiko
K
Third Department of Internal Medicine, Kyorin University School of Medicine.
Ozawa
Sachihiko
S
Ishida
Hitoshi
H
D000818:Animals; D003924:Diabetes Mellitus, Type 2 / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy; D005230:Fatty Acids, Nonesterified / Q000009:adverse effects; D018149:Glucose Intolerance / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000378:metabolism; D007333:Insulin Resistance; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000503:physiopathology; D018384:Oxidative Stress; D011972:Receptor, Insulin / Q000502:physiology
D005230:Fatty Acids, Nonesterified; D007004:Hypoglycemic Agents; D007328:Insulin; D011972:Receptor, Insulin